Monopar Therapeutics
MNPR
#8837
Rank
HK$0.69 B
Marketcap
HK$131.23
Share price
7.31%
Change (1 day)
808.34%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2023 (TTM): -HK$6.03

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$5.99. In 2022 the company made an earnings per share (EPS) of -HK$6.45 a decrease over its 2021 EPS that were of -HK$5.75.

EPS history for Monopar Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$6.03-6.48%
2022-HK$6.4512.16%
2021-HK$5.7527.59%
2020-HK$4.5143.71%
2019-HK$3.1433.52%
2018-HK$2.35-80.97%
2017-HK$12.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.95 183.12%๐Ÿ‡บ๐Ÿ‡ธ USA